Bio Medica Laboratories Ltd (NSE:BMLL) Share Price

Company Profile

Business description
Bio Medica Laboratories Ltd is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures generic drugs in the form of injectables, namely Liquid Injections and Dry Powder Injections. These injectables are available in both single-dose and multi-dose forms, catering to both human and veterinary needs. Its products address a wide range of medical needs and preferences. The majority of revenue is derived from the sales of Liquid injections. Geographically, it operates predominantly in India, and internationally, it exports to Afghanistan.
Contact
Sanwer Road, Plot No. 11B-11C
Sector-E, Industrial Area
Industrial Estate - Indore
IndoreMP452015
IND
T: +91 9827210008
https://www.biomedica.co.in
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 March 2027
Employees
56

Recommended

Expensive healthcare share limited by its core addressable market.

Brian Han | 09 June 2026

ASX tech share raises funds to facilitate customer AI spend.

Roy Van Keulen | 08 June 2026

Investors are paying a steep price relative to the underlying business quality, PitchBook research says.

Harrison Rolfes | 05 June 2026

Index	Last price	Change	% Change
All Ordinaries	8,857.00	48.10	0.55%
CAC 40	8,161.83	41.60	-0.51%
DAX 40	24,195.31	237.75	-0.97%
Dow JONES (US)	49,918.78	953.33	-1.87%
FTSE 100	10,254.81	27.48	0.27%
HKSE	24,407.96	157.94	-0.64%
NASDAQ	25,169.50	509.32	-1.98%
Nikkei 225	64,179.27	1,237.36	-1.89%
NZX 50 Index	13,253.65	49.57	0.38%
S&P 500	7,266.99	119.66	-1.62%
S&P/ASX 200	8,653.30	61.90	0.72%
SSE Composite Index	3,993.23	16.80	-0.42%